In three distinct transplantable tumor models, LAG-3 and PD-1 have been shown to be co-expressed on tumor-infiltrating lymphocytes, and blockade of both pathways had synergistic effects on the anti-tumor CD8+ T cell response (31). The gene discussed is PDCD1; the disease is neoplasm.